Anita Rachlis

Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival

Mari M. Kitahata, Stephen J. Gange, Alison G. Abraham et al. · New England Journal of Medicine · 2009 · 1.1K citations · Full text

Public Health, Pharmacotherapy, Hiv Prevention +11

Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

Schlomo Staszewski, Javier O Morales-Ramirez, Karen T. Tashima et al. · New England Journal of Medicine · 1999 · 1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

François Raffi, Anita Rachlis, Hans‐Jürgen Stellbrink et al. · The Lancet · 2013 · 546 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Cumulative Incidence of Cancer Among Persons With HIV in North America

Michael J. Silverberg, Bryan Lau, Chad J. Achenbach et al. · Annals of Internal Medicine · 2015 · 330 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

A Comparison of Two Regimens for the Treatment of<i>Mycobacterium avium</i>Complex Bacteremia in AIDS: Rifabutin, Ethambutol, and Clarithromycin versus Rifampin, Ethambutol, Clofazimine, and Ciprofloxacin

Stephen D. Shafran, Joel Singer, Donald P. Zarowny et al. · New England Journal of Medicine · 1996 · 308 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +12